ARHGDIB 抗体
(rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
Members of the Rho (or ARH) protein family (see MIM 165390) and other Ras-related small GTP-binding proteins (see MIM 179520) are involved in diverse cellular events, including cell signaling, proliferation, cytoskeletal organization, and secretion. The GTP-binding proteins are active only in the GTP-bound state. At least 3 classes of proteins tightly regulate cycling between the GTP-bound and GDP-bound states: GTPase-activating proteins (GAPs), guanine nucleotide-releasing factors (GRFs), and GDP-dissociation inhibitors (GDIs). The GDIs, including ARHGDIB, decrease the rate of GDP dissociation from Ras-like GTPases (summary by Scherle et al., 1993 [PubMed 8356058]).[supplied by OMIM, Dec 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| ARHGDIB 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 125-137) | 人, Cow, 犬, 马, 小鸡, Pig, Bat, 猴 | 小鼠 Monoclonal |
|
|
|
| ARHGDIB 抗体 (AA 2-86) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 1-201) | 人 | 小鼠 Polyclonal |
|
|
|
| ARHGDIB 抗体 | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| ARHGDIB 抗体 (AA 1-201) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant ARHGDIB 抗体 | 人 | 兔 Monoclonal |
|
|
|
| ARHGDIB 抗体 | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 1-201) | 人 | 小鼠 Monoclonal |
|
|
|
| ARHGDIB 抗体 (N-Term) | 人 | 山羊 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 21-120) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 66-201) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 1-201) | 人 | 小鼠 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 160-188) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 1-201) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 160-188) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 160-188) (APC) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| ARHGDIB 抗体 (AA 160-188) (FITC) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
1 reference - 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB33730
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 160-188, C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 2-86
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-201
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-201
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 24GB6895
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- ELISA (ELISA: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2C12-B6
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 1-201
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 21-120
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 66-201
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-201
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 160-188
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-201
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 160-188
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 160-188
Primary Antibody
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 160-188
Latest Publications for our ARHGDIB 抗体
: "Transcriptomic Analysis of the Mechanisms for Alleviating Psoriatic Dermatitis Using Taodan Granules in an Imiquimod-Induced Psoriasis-like Mouse Model." in: Frontiers in pharmacology, Vol. 12, pp. 632414, (2021) (PubMed).
: "RhoGDI? Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation." in: The Journal of biological chemistry, Vol. 290, Issue 17, pp. 11119-29, (2015) (PubMed).
: "Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes." in: Journal of autoimmunity, Vol. 58, pp. 78-89, (2015) (PubMed).
: "RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer." in: Clinical & experimental metastasis, Vol. 31, Issue 7, pp. 805-15, (2014) (PubMed).
: "Proteomic analyses of age related changes in A.BY/SnJ mouse hearts." in: Proteome science, Vol. 11, pp. 29, (2014) (PubMed).
: "Differential regulation of caspase-9 by ionizing radiation- and UV-induced apoptotic pathways in thymic cells." in: Mutation research, Vol. 688, Issue 1-2, pp. 78-87, (2010) (PubMed).
: "Genetic susceptibility to distinct bladder cancer subphenotypes." in: European urology, Vol. 57, Issue 2, pp. 283-92, (2010) (PubMed).
: "Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells." in: Journal of leukocyte biology, Vol. 85, Issue 1, pp. 71-80, (2008) (PubMed).
: "Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping." in: Molecular & cellular proteomics : MCP, Vol. 6, Issue 6, pp. 987-99, (2007) (PubMed).
: "Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis." in: Oncology reports, Vol. 17, Issue 6, pp. 1383-9, (2007) (PubMed).
: "RhoGDI? Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation." in: The Journal of biological chemistry, Vol. 290, Issue 17, pp. 11119-29, (2015) (PubMed).
: "Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes." in: Journal of autoimmunity, Vol. 58, pp. 78-89, (2015) (PubMed).
: "RhoGDI2 is associated with HGF-mediated tumor invasion through VEGF in stomach cancer." in: Clinical & experimental metastasis, Vol. 31, Issue 7, pp. 805-15, (2014) (PubMed).
: "Proteomic analyses of age related changes in A.BY/SnJ mouse hearts." in: Proteome science, Vol. 11, pp. 29, (2014) (PubMed).
: "Differential regulation of caspase-9 by ionizing radiation- and UV-induced apoptotic pathways in thymic cells." in: Mutation research, Vol. 688, Issue 1-2, pp. 78-87, (2010) (PubMed).
: "Genetic susceptibility to distinct bladder cancer subphenotypes." in: European urology, Vol. 57, Issue 2, pp. 283-92, (2010) (PubMed).
: "Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells." in: Journal of leukocyte biology, Vol. 85, Issue 1, pp. 71-80, (2008) (PubMed).
: "Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping." in: Molecular & cellular proteomics : MCP, Vol. 6, Issue 6, pp. 987-99, (2007) (PubMed).
: "Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis." in: Oncology reports, Vol. 17, Issue 6, pp. 1383-9, (2007) (PubMed).
Aliases for ARHGDIB 抗体
Rho GDP dissociation inhibitor (GDI) gamma (arhgdig) 抗体Rho GDP dissociation inhibitor (GDI) beta S homeolog (arhgdib.S) 抗体
Rho GDP dissociation inhibitor beta (ARHGDIB) 抗体
Rho GDP dissociation inhibitor (GDI) beta (arhgdib) 抗体
Rho, GDP dissociation inhibitor (GDI) beta (Arhgdib) 抗体
Rho GDP dissociation inhibitor beta (Arhgdib) 抗体
ARHGDIB 抗体
arhgdib 抗体
D4 抗体
gdia2 抗体
GDIA2 抗体
GDID4 抗体
Gdid4 抗体
Ly-GDI 抗体
LYGDI 抗体
MGC69067 抗体
RAP1GN1 抗体
rhodgi-2 抗体
rhodgi2 抗体
RhoGDI2 抗体
zgc:65966 抗体
您还需要查找其他产品吗？
You are here:
